GlassScriptPhysician profile
Kamran Jamshidinia
NPI 1265489546
$894.40
in general payments reported to CMS, 2019-2025
13 companies · $260 in 2025
The $260 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.15 · 2020: $121 · 2021: $45.00 · 2022: $86.92 · 2023: $119 · 2024: $224 · 2025: $260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $602.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $190.79 | 2022-2025 | Inceptiv |
| Inari Medical, INC. | $169.59 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Musculoskeletal Transplant Foundation INC. | $120.67 | 2020 | |
| Polynovo North America LLC | $65.95 | 2025 | Novosorb Btm |
| Paratek Pharmaceuticals, INC. | $46.62 | 2023-2024 | Nuzyra |
| Smith+Nephew, INC. | $46.13 | 2022-2025 | Collagenase Santyl |
| Zimmer Biomet Holdings, INC. | $45.00 | 2021 | |
| Angiodynamics, INC. | $43.90 | 2022 | |
| Paragon 28, INC. | $39.15 | 2019 | |
| Kci USA, INC. | $38.63 | 2023 | V.A.C. Veraflo, V.A.C.Ulta, V.A.C.Instill |
| Janssen Scientific Affairs, LLC | $34.77 | 2023 | Xarelto |
| Orthofix Medical, INC. | $31.15 | 2024 | Physio-Stim |
| Abbott Laboratories | $22.05 | 2023 | Proclaim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kamran Jamshidinia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.